Showing 1,581 - 1,600 results of 60,794 for search '(( 50 ((ns decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (we decrease)) ))', query time: 1.12s Refine Results
  1. 1581
  2. 1582
  3. 1583
  4. 1584
  5. 1585
  6. 1586

    Flow chart. by Raphaele Houlbracq (20558509)

    Published 2025
    “…The difference in overall prevalence of OASI between 2010 (0.7%) and 2021 (1.0%) was not statistically significant after adjustment (aRR 1.24, 95% CI 0.91 to 1.68). By groups of classification, the prevalence of OASI increased significantly only in Group 2b [nulliparous term cephalic singleton with spatula delivery] from 2.6% (95% CI 1.2 to 5.6) in 2010 to 9.6% (95% CI 6.2 to 14.7) in 2021 (aRR 3.69, 95% CI 1.50 to 9.09), and did not differ statistically significantly in Group 2a [nulliparous term cephalic singleton with forceps delivery] from 3.2% (95% CI 1.8 to 5.7) in 2010 to 5.7% (95% CI 3.4 to 9.5) in 2021 (aRR 1.78, 95% CI 0.81 to 3.90).…”
  7. 1587

    Data used to generate Fig 5. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…However, this irradiation dose could be reduced to 5 Gy to sterilize both males and females infected with <i>Wolbachia</i>. …”
  8. 1588

    Data used to generate Table 5. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…However, this irradiation dose could be reduced to 5 Gy to sterilize both males and females infected with <i>Wolbachia</i>. …”
  9. 1589
  10. 1590
  11. 1591

    DataSheet_1_Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.pdf by Yun Ji (464484)

    Published 2022
    “…However, the continuous virus evolution requires diverse mAb options to combat variants. Here we describe two fully human mAbs, amubarvimab (BRII-196) and romlusevimab (BRII-198) that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein and effectively neutralize SARS-CoV-2 variants. …”
  12. 1592

    DPT3 Stat EDHS for five surveys. by Hailu Fekadu (17797638)

    Published 2024
    “…Regarding educational status, inequality (RII) show decreasing pattern from 7.2% (2000) to 1.5% in(2019). …”
  13. 1593
  14. 1594

    Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma by Harry A. Quigley (695817)

    Published 2015
    “…</p><p>Methods</p><p>We produced IOP increase in CD1 mice and performed unilateral optic nerve crush. …”
  15. 1595
  16. 1596
  17. 1597
  18. 1598
  19. 1599
  20. 1600